来自MSN24 分钟
Goldman Sachs Downgrades REGENXBIO (RGNX)
Fintel reports that on February 11, 2025, Goldman Sachs downgraded their outlook for REGENXBIO (NasdaqGS:RGNX) from Buy to ...